Letter: new thresholds need to be defined when using point of care assays to monitor infliximab trough levels in IBD patients
| Image |  |
|---|---|
| Description | scientific article published on 01 June 2018 |
| Author/s | |
| Publication date | June 1, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |